Welcome to convergence, corporate governance style. A flurry of reforms have swept through boardrooms in Corporate America this spring. Chief among are them majority voting election of directors and greater disclosure of executive compensation, but also in tow are less-noticed moves like abolition of poison pills and staggered boards. All those separate trends have been dissected ad nauseam this proxy season.
Less understood, however, are the new dynamics likely to be unleashed once these reforms all align in favor of the shareholder.
